These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 35485527)

  • 1. Tau protein quantification in skin biopsies differentiates tauopathies from alpha-synucleinopathies.
    Vacchi E; Lazzarini E; Pinton S; Chiaro G; Disanto G; Marchi F; Robert T; Staedler C; Galati S; Gobbi C; Barile L; Kaelin-Lang A; Melli G
    Brain; 2022 Aug; 145(8):2755-2768. PubMed ID: 35485527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the movement disorder society criteria for the diagnosis of 4-repeat tauopathies.
    Respondek G; Grimm MJ; Piot I; Arzberger T; Compta Y; Englund E; Ferguson LW; Gelpi E; Roeber S; Giese A; Grossman M; Irwin DJ; Meissner WG; Nilsson C; Pantelyat A; Rajput A; van Swieten JC; Troakes C; Höglinger GU;
    Mov Disord; 2020 Jan; 35(1):171-176. PubMed ID: 31571273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tau seeding activity in skin biopsy differentiates tauopathies from synucleinopathies.
    Dellarole IL; Vacchi E; Ruiz-Barrio I; Pinton S; Raimondi A; Rossi S; Morandi S; Bianco G; Begum Bacinoglu M; Lombardo A; Celauro L; Staedler C; Galati S; Pagonabarraga J; Kulisevsky J; Legname G; Gobbi C; Kaelin-Lang A; Moda F; Melli G
    NPJ Parkinsons Dis; 2024 Jun; 10(1):116. PubMed ID: 38879633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration.
    Riku Y; Iwasaki Y; Ishigaki S; Akagi A; Hasegawa M; Nishioka K; Li Y; Riku M; Ikeuchi T; Fujioka Y; Miyahara H; Sone J; Hattori N; Yoshida M; Katsuno M; Sobue G
    Brain; 2022 Aug; 145(8):2769-2784. PubMed ID: 35274674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies.
    Chalmers KA; Love S
    J Neuropathol Exp Neurol; 2007 Nov; 66(11):1019-26. PubMed ID: 17984683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropathological correlates of structural and functional imaging biomarkers in 4-repeat tauopathies.
    Spina S; Brown JA; Deng J; Gardner RC; Nana AL; Hwang JL; Gaus SE; Huang EJ; Kramer JH; Rosen HJ; Kornak J; Neuhaus J; Miller BL; Grinberg LT; Boxer AL; Seeley WW
    Brain; 2019 Jul; 142(7):2068-2081. PubMed ID: 31081015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration.
    Tedeschi G; Litvan I; Bonavita S; Bertolino A; Lundbom N; Patronas NJ; Hallett M
    Brain; 1997 Sep; 120 ( Pt 9)():1541-52. PubMed ID: 9313638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Tau Proteoforms in Health and Disease.
    Waheed Z; Choudhary J; Jatala FH; Fatimah ; Noor A; Zerr I; Zafar S
    Mol Neurobiol; 2023 Sep; 60(9):5155-5166. PubMed ID: 37266762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vivo Assessment of Neuroinflammation in 4-Repeat Tauopathies.
    Palleis C; Sauerbeck J; Beyer L; Harris S; Schmitt J; Morenas-Rodriguez E; Finze A; Nitschmann A; Ruch-Rubinstein F; Eckenweber F; Biechele G; Blume T; Shi Y; Weidinger E; Prix C; Bötzel K; Danek A; Rauchmann BS; Stöcklein S; Lindner S; Unterrainer M; Albert NL; Wetzel C; Rupprecht R; Rominger A; Bartenstein P; Herms J; Perneczky R; Haass C; Levin J; Höglinger GU; Brendel M
    Mov Disord; 2021 Apr; 36(4):883-894. PubMed ID: 33245166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion tensor magnetic resonance imaging for single subject diagnosis in neurodegenerative diseases.
    Sajjadi SA; Acosta-Cabronero J; Patterson K; Diaz-de-Grenu LZ; Williams GB; Nestor PJ
    Brain; 2013 Jul; 136(Pt 7):2253-61. PubMed ID: 23729473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SCRN1: A cerebrospinal fluid biomarker correlating with tau in Alzheimer's disease.
    Weiner S; Sauer M; Brinkmalm G; Constantinescu J; Constantinescu R; Gomes BF; Becker B; Nellgård B; Dalla K; Galasko D; Zetterberg H; Blennow K; Gobom J
    Alzheimers Dement; 2023 Oct; 19(10):4609-4618. PubMed ID: 36946611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement system changes in blood in Parkinson's disease and progressive Supranuclear Palsy/Corticobasal Syndrome.
    Khosousi S; Hye A; Velayudhan L; Bloth B; Tsitsi P; Markaki I; Svenningsson P
    Parkinsonism Relat Disord; 2023 Mar; 108():105313. PubMed ID: 36739794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of Skin α-Synuclein Deposits Discriminates Parkinson's Disease from Progressive Supranuclear Palsy and Corticobasal Syndrome.
    Giannoccaro MP; Avoni P; Rizzo G; Incensi A; Infante R; Donadio V; Liguori R
    J Parkinsons Dis; 2022; 12(2):585-591. PubMed ID: 34864689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligomeric α-synuclein and tau aggregates in NDEVs differentiate Parkinson's disease from atypical parkinsonisms.
    Meloni M; Agliardi C; Guerini FR; Zanzottera M; Bolognesi E; Picciolini S; Marano M; Magliozzi A; Di Fonzo A; Arighi A; Fenoglio C; Franco G; Arienti F; Saibene FL; Navarro J; Clerici M
    Neurobiol Dis; 2023 Jan; 176():105947. PubMed ID: 36481435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of multiple system atrophy mimicking Parkinson's disease or progressive supranuclear palsy.
    Miki Y; Tsushima E; Foti SC; Strand KM; Asi YT; Yamamoto AK; Bettencourt C; Oliveira MCB; De Pablo-Fernández E; Jaunmuktane Z; Lees AJ; Wakabayashi K; Warner TT; Quinn N; Holton JL; Ling H
    Brain; 2021 May; 144(4):1138-1151. PubMed ID: 33822892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tau gene A0 polymorphism in progressive supranuclear palsy and related neurodegenerative diseases.
    Morris HR; Janssen JC; Bandmann O; Daniel SE; Rossor MN; Lees AJ; Wood NW
    J Neurol Neurosurg Psychiatry; 1999 May; 66(5):665-7. PubMed ID: 10209184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E epsilon 4 is a determinant for Alzheimer-type pathologic features in tauopathies, synucleinopathies, and frontotemporal degeneration.
    Josephs KA; Tsuboi Y; Cookson N; Watt H; Dickson DW
    Arch Neurol; 2004 Oct; 61(10):1579-84. PubMed ID: 15477512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
    Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive Supranuclear Palsy and Corticobasal Degeneration.
    Coughlin DG; Dickson DW; Josephs KA; Litvan I
    Adv Exp Med Biol; 2021; 1281():151-176. PubMed ID: 33433875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Imaging of Extrapyramidal Movement Disorders With Dementia: The 4R Tauopathies.
    Frey KA
    Semin Nucl Med; 2021 May; 51(3):275-285. PubMed ID: 33431202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.